Anatomic Stage IV Breast Cancer AJCC v8 Recruiting Phase 1 Trials for Tamoxifen (DB00675)

IndicationStatusPhase
DBCOND0109665 (Anatomic Stage IV Breast Cancer AJCC v8)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03554044Talimogene Laherparepvec With Paclitaxel or Endocrine Therapy in Treating Participants With Metastatic, Unresectable, or Recurrent HER2- Negative Breast CancerTreatment